STEFANIE ELLIS: Open Payments
NPI 1558389114 · VAN BUREN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,932 in 78 payments from 16 companies in 2025. Trend: 2023 $1,468 · 2024 $1,884 · 2025 $1,932
Food & beverage: $1,932
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $631 |
| ABBVIE INC. | 14 | $334 |
| Amgen Inc. | 11 | $246 |
| Axsome Therapeutics, Inc. | 4 | $173 |
| Novo Nordisk Inc | 5 | $87 |
| PFIZER INC. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Antares Pharma, Inc. | 3 | $53 |
| Exact Sciences Corporation | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
Products named: BREZTRI, AIRSUPRA, VRAYLAR, Auvelity, EVENITY, OTEZLA, QULIPTA, UBRELVY.
Industry payments across AR — which companies pay providers there.
